Neuropathic Pain (Part I). An update on its definition, mechanisms and diagnosis

Authors

  • Pablo R. Brumovsky Faculty of Biomedical Sciences (FCB) of the Austral University (UA). Argentina.
  • Susana González Institute of Biology and Experimental Medicine (IByME). Argentina
  • Jorge E. Vivé Neurosurgery Unit, HIGA Evita, Lanús, Buenos Aires. Argentina
  • Eduardo D. Marchevsky Special Interest Group on Neuropathic Pain (GIEDN) of the Argentine Association for the Study of Pain (AAED).

DOI:

https://doi.org/10.47924/neurotarget2011289

Keywords:

neuropathic pain, criterion, diagnosis, neuropathy, neuron, somatosensory

Abstract

The correct diagnosis of neuropathic pain remains a reason for intense debate. In fact, definitive proof for the diagnosis of this type of pain is still scarce; its identification is mostly of clinical nature. Moreover, guides in Spanish with algorithms orienting the diagnosis and treatment of neuropathic pain are unavailable in Argentina. In the present review, and based on recent efforts of the international community for the creation of a diagnostic criteria that allow the correct identification of neuropathic pain, we have focused in the following objectives: 1) to offer an updated view of neuropathic pain, its definition, clinical manifestations and epidemiology, as well as the outlining of its potential mechanisms; 2) to suggest strategies and criteria that may contribute to an adequate diagnosis of patients with neuropathic pain; 3) to facilitate the selection of patients for the design of clinical essays, and 4) to take the first step for the interaction and communication between Physicians, and Clinical and Basic Scientists involved in the study of pain.

Metrics

Metrics Loading ...

References

Baron R. Mechanisms of disease: neuropathic pain a clinical perspective. Nat Clin Pract Neurol. 2006;2(2):95-106.

Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9(8):807-19.

Lynch M. Pain as the fifth vital sign. J Intraven Nurs. 2001;24(2):85-94.

Chanvej L, Petpichetchian W, Kovitwanawong N, Chaibandit C, Vorakul C, Khunthong T. A chart audit of postoperative pain assessment and documentation: the first step to implement pain assessment as the fifth vital sign in a University Hospital in Thailand. J Med Assoc Thai. 2004;87(12):1447-53.

Stenbach RA. Pain patiens: traits and treatment. New York: Academic Press; 1974.

Merskey H, Bogduk N, editors. Classification of chronic pain. Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. 2nd ed. Seattle: IASP Press; 1994. p. 209-14.

Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008;70(18):1630-5.

Backonja MM. Defining neuropathic pain. Anesth Analg. 2003;97(3):785- 90. Erratum in: Anesth Analg. 2004;98(1):67.

Bennett GJ. Neuropathic pain: a crisis of definition? Anesth Analg. 2003;97(3):619-20.

Jensen TS, Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain 2003;102(1-2):1-8.

Sah DW, Ossipo MH, Porreca F. Neurotrophic factors as novel therapeutics for neuropathic pain. Nat Rev Drug Discov. 2003;2(6):460-72.

Hunt SP, Koltzenburg M, editors. The neurobiology of pain. New York: Oxford University Press; 2005.

Hökfelt T, Brumovsky P, Villar M. Retrograde cellular changes after nerve injury. In: Schmidt RF, Willis WD, editors. Encyclopedia of Pain. New York: Springer; 2007. p. 2122-6.

Zhuang ZY, Kawasaki Y, Tan PH, Wen YR, Huang J, Ji RR. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav Immun. 2007;21(5):642-51.

Bettoni I, Comelli F, Rossini C, Granucci F, Giagnoni G, Peri F, et al. Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia 2008;56(12):1312-9.

Haanpää M, Attal N, Backonja M, Baron R, Bennett M, Bouhassira D, et al. NeuPSIG guidelines on neuropathic pain assessment. Pain 2011;152(1):14- 27. Comment in: Pain 2011;152(1):2-3, Pain 2011;152(7):1682; author reply 1683-4.

Hassan AE, Saleh HA, Baroudy YM, Abdul-Rahman KI, Najjar MW, Kazi MS, et al. Prevalence of neuropathic pain among patients suffering from chronic low back pain in Saudi Arabia. Saudi Med J. 2004;25(12):1986-90.

Montero J, Gutiérrez E, Pardo J, Navarro C; PREVADOL. Estudio de prevalencia, incidencia y caracterización del dolor neuropático en consultas de Neurología. Estudio PREVADOL. Neurología 2005;20(8):385-9.

Carneado-Ruiz J, Morera-Guitart J, Alfaro-Sáez A, Turpín-Fenoll L, Serna-Candel C, Matías-Guiu Guía J. El dolor neuropático como motivo de consulta en Neurología: análisis de su frecuencia. Rev Neurol. 2005;41(11):643-8.

Freynhagen R, Baron R, Tölle T, Stemmler E, Gockel U, Stevens M, et al. Screening of neuropathic pain components in patients with chronic back pain associated with nerve root compression: a prospective observational pilot study (MIPORT). Curr Med Res Opin. 2006;22(3):529-37.

Pérez C, Saldaña MT, Navarro A, Vilardaga I, Rejas J. Prevalence and characterization of neuropathic pain in a primary-care setting in Spain: a cross-sectional, multicentre, observational study. Clin Drug Investig. 2009;29(7):441-50.

El Sissi W, Arnaout A, Chaarani MW, Fouad M, El Assuity W, Zalzala M, et al. Prevalence of neuropathic pain among patients with chronic low-back pain in the Arabian Gulf Region assessed using the leeds assessment of neuropathic symptoms and signs pain scale. J Int Med Res. 2010;38(6):2135- 45.

Baños JE, Bosch F. Conceptos generales en algología. En: Aliaga A, Baños JE, Barutell C, Molet J, Rodríguez de la Serna A, editores. Tratamiento del dolor. Teoría y práctica. Barcelona: MRC; 1995. p. 1-8.

Freynhagen R, Baron R. The evaluation of neuropathic components in low back pain. Curr Pain Headache Rep. 2009;13(3):185-90.

Wall PD, Melzack R, editors. Textbook of pain. 2nd ed. Edinburgh, UK: Churchill Livingstone; 1989.

Fishbain D. Evidence-based data on pain relief with antidepressants. Ann Med. 2000;32(5):305-16.

Rivera Canudas MV. Dolor neuropático. Rev Soc Esp Dolor. 2010;17(3):137-8.

Guevara-López U, Covarrubias-Gómez A, Hernández-Jiménez S, Palapa-García R, Acosta-Alanís FJ, Aragón G, et al; Grupo de Consenso para el Manejo del Dolor Neuropático. Tendencias de diagnóstico y tratamiento del dolor neuropático en México. Rev Mex Anest. 2006;29(1):9-14.

Lynch ME, Clark AJ, Moulin DE, Watson CP. Modifications are suggested for the Special Interest Group (SIG) on Neuropathic Pain proposed definition and guidelines for neuropathic pain. Pain. 2011;152(7):1682; author reply 1683-4. Comment on: Pain. 2011;152(1):14-27.

Drake: Gray s Anatomy for Students, 2nd Edition. Copyright 2009 by Churchill Livingstone, an imprint of Elsevier, Inc. 31. Jänig W, Research Group Autonomic Nervous System and Pain. Neural mechanisms of neuropathic pain [monografía en Internet]. Kiel, Germany [citado 20 Oct 2011]. Disponible en: http://www.physiologie.uni-kiel.de/ homepages_mitarbeiter/jaenig/neu/hompage.html

Published

2011-08-01

How to Cite

1.
Brumovsky PR, González S, Vivé JE, Marchevsky ED. Neuropathic Pain (Part I). An update on its definition, mechanisms and diagnosis. NeuroTarget [Internet]. 2011 Aug. 1 [cited 2025 Dec. 25];6(2):96-103. Available from: https://neurotarget.com/index.php/nt/article/view/289